Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Kevin White, MD

Can Rapamycin Reverse Brain Aging? Dr. Veronica Galvan on Alzheimer's Research Surprising Even Her

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

In this episode, Dr. Kevin White sits down with Dr. Veronica Galvan, Presidential Professor at the University of Oklahoma Health Sciences Center and Director of the Oklahoma Nathan Shock Center on Aging. Most people think Alzheimer's is caused by a buildup of "bad" proteins in the brain. The real story is more complicated, and more hopeful. Galvan has spent her career studying what actually drives Alzheimer's disease, and her research has uncovered something surprising: a common, decades-old drug may be able to reverse brain damage that was thought to be permanent. Together they explore: - What's really happening in the brain during Alzheimer's, and why the "bad protein" explanation is incomplete - Why aging itself, not genetics, is the single biggest risk factor for Alzheimer's disease - What your APOE gene type (2, 3, or 4) actually means for your risk - How rapamycin, a drug originally used for organ transplants, reversed brain damage in animal studies "It wasn't improving. It was restoring." — Dr. Veronica Galvan - Why some people's brains show significant Alzheimer's damage on scans but never lose their memory or function - The simplest, most overlooked factor that can change your brain's trajectory as you age - Along the way, Galvan shares what pulled her from virology into Alzheimer's research, why she believes large-scale human trials on rapamycin are long overdue, and what she'd study next if funding were no object. Whether you have a family history of dementia, want to understand the research behind the headlines, or are simply thinking ahead about how to protect your brain, this episode offers a clearer picture of where the science actually stands. Guest Dr. Veronica Galvan Presidential Professor, University of Oklahoma Health Sciences Center Director, Oklahoma Nathan Shock Center on Aging Follow The Daily Apple for weekly conversations on longevity, performance, prevention, nutrition, exercise, and the science of living well. If you enjoyed this episode, please subscribe, leave a review, and share it with someone who's committed to living a longer, healthier life. www.primehealthassociates.com Instagram: @KevinWhiteMD YouTube: @KevinWhiteMD 🎧 From The Daily Apple Podcast with Dr. Kevin White 🎙️ Listen to the full episode on Spotify, Apple, or YouTube

Kevin White, MD · 71 min · Source published: 2026-09-03

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…